Bioorthogonal transformations are chemical reactions that use pathways which biological
processes do not access. Bioorthogonal chemistry provides new approaches for imaging …

Bioorthogonal transition metal catalysts (TMCs) transform therapeutically inactive molecules
(pro-drugs) into active drug compounds. Inorganic nanoscaffolds protect and solubilize …

Bioorthogonal catalysis using transition-metal catalysts (TMCs) provides a toolkit for the in
situ generation of imaging and therapeutic agents in biological environments. Integrating …

Bioorthogonal chemistry refers to any chemical reactions that can occur inside of living
systems without interfering with native biochemical processes, which has become a …

Nanozymes, the next-generation artificial enzymes, are nanomaterials with enzyme-like
characteristics and have been widely used in detection, disease diagnosis, biological …

Bioorthogonal catalysis via transition metal catalysts (TMCs) enables the generation of
therapeutics locally through chemical reactions not accessible by biological systems. This …

Nanozymes mimic the function of enzymes, which drive essential intracellular chemical
reactions that govern biological processes. They efficiently generate or degrade specific …

Macrophages migrate to tumor sites by following chemoattractant gradients secreted by
tumor cells, providing a truly active targeting strategy for cancer therapy. However …

During the last decade, there has been a tremendous interest for developing non‐natural
biocompatible transformations in biologically relevant media. Among the different …

Bioorthogonal catalysis mediated by transition metal catalysts (TMCs) provides controlled in
situ activation of prodrugs through chemical reactions that do not interfere with cellular …